Study of CD38 and CD56 in Chronic Myeloid Leukemia | NCT07740603

NCT07740603

Overview

NCT ID: NCT07740603
Lead Sponsor: Sohag UniversityOTHER
Official Title: Aberrant Expression of CD56 on CD38 Positive Neutrophils as a Novel Diagnostic Tool in Chronic Myeloid Leukemia
Brief Summary: Chronic myeloid leukemia is a myelo-proliferative neoplasm characterized by abnormal proliferation of myeloid cells. There is an accumulation of mature granulocytes in the blood and bone marrow.

The aim of the study is to study expression of CD38 and CD56 in patients with Chronic myeloid leukemia.
Conditions: Chronic Myeloid Leukemia (CML)
Interventions: cd 38 and cd 56

Ages Eligible for Study: Child (0-17)Adult (18-64)Older Adult (65+)
Sexes Eligible for Study: All
Accepts Healthy Volunteers?: Yes
Eligibility Criteria: Inclusion Criteria:

patients with chronic myeloid leukemia

Exclusion Criteria:

other hematological diseases

Central Contacts: Menna Mostafa ZakiContact
mennazaki133@gmail.com01152386116